Elias Bouchi: Celebrating Hemostasis in EEMEA!
Elias Bouchi, Lead of the marketing strategy for the EEMEA region at Werfen, shared on LinkedIn:
”Celebrating Hemostasis in EEMEA!
2025 is a milestone year for Hemostasis across our region—driving awareness, sharing knowledge, and introducing innovations that redefine laboratory medicine.
What made this year remarkable?
Awareness and Education – From the impactful Thrombosis Awareness Campaign to two inspiring podcast seasons of EEMEA Talks Hemostasis, we kept conversations alive and meaningful.
Scientific Exchange – Our Scientific Seminars united hundreds of experts, featuring a joint APS session and the 16th Edition of the Hemostasis Seminar —continuing our tradition of deep scientific dialogue.
Innovation at the Forefront – The ACL TOP 70 Series, HemoHub, and Astelia set new standards, while initiatives like 70×70 Grow Together proved that innovation and social responsibility go hand in hand.
A big thank you to all colleagues, speakers, participants, and partners who made this possible.
Prepare for 2026 and stay tuned for new projects that will shape the future of Hemostasis!”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?